Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,865,688

« Back to Dashboard

Which drugs does patent 8,865,688 protect, and when does it expire?

Patent 8,865,688 protects APRISO and is included in one NDA. There has been one Paragraph IV challenge on Apriso.

This patent has fifteen patent family members in twelve countries.

Summary for Patent: 8,865,688

Title:Compositions and methods for treatment of bowel diseases with granulated mesalamine
Abstract: Disclosed are methods for treating gastrointestinal disorders, e.g., Crohn's disease, ulcerative colitis, and diverticular disease, with a granulated mesalamine formulation. Some formulations use granulated mesalamine in capsule form. Also included are methods to extend remission of ulcerative colitis by administration of a once-daily dosage of granulated mesalamine.
Inventor(s): Forbes; William (Raleigh, NC)
Assignee: Dr. Falk Pharma GmbH (DE)
Application Number:12/573,081
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Valeant Pharms IntlAPRISOmesalamineCAPSULE, EXTENDED RELEASE;ORAL022301-001Oct 31, 2008RXYesYes► Subscribe► Subscribe► SubscribeFOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,865,688

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine108838► Subscribe
New Zealand592049► Subscribe
Mexico2011003595► Subscribe
Japan5740306► Subscribe
Japan2012504658► Subscribe
Israel212057► Subscribe
European Patent Office2334178► Subscribe
Eurasian Patent Organization022886► Subscribe
Eurasian Patent Organization201100565► Subscribe
China102238868► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Johnson and Johnson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: